Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane Nutraceutical for Schizophrenia
NCT02810964Phase 2Completed
- Sponsor
- Sheppard Pratt
- Start
- Feb 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of broccoli seed and sprout extract in schizophrenia, schizoaffective disorder, sponsored by Sheppard Pratt. Started Feb 2017; status: completed.
02
Drugs
broccoli seed and sprout extract
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02810964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810964.